Ophthalmic Case Studies and Novel Approach

In a recent small-scale randomized controlled trial, the Oculeve Intranasal Lacrimal Neurostimulator (Allergan) was found to increase the production of aqueous tears and the secretion of goblet cells. This handheld device functions by administering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve within the nasal cavities. This innovative approach presents a potential new avenue for managing dry eye disease, which currently relies heavily on artificial tears and anti-inflammatory medications.

    Related Conference of Ophthalmic Case Studies and Novel Approach

    February 17-18, 2025

    11th Global Ophthalmology Meeting

    Amsterdam, Netherlands
    February 24-25, 2025

    9th World Congress on Eye and Vision

    Madrid, Spain
    March 17-18, 2025

    39th European Ophthalmology Congress

    Berlin, Germany
    April 07-08, 2025

    6th World congress on Ophthalmology and Optometry

    Amsterdam, Netherlands
    April 29-30, 2025

    35th International Congress on Vision Science and Eye

    Barcelona, Spain
    April 29-30, 2025

    6th World Congress on Ophthalmology and Vision Science

    Barcelona, Spain
    June 12-13, 2025

    6th International Conference on Optometry

    London, UK
    June 17-18, 2025

    25th Global Ophthalmologists Annual Meeting

    Copenhagen, Denmark

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in